Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

brilacidin × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Stomatitis 1 Mucositis 1 Head and Neck Neoplasms 1

Interventions

Exercise 25 Metformin 19 Surveys and Questionnaires 15 Methods 12 Early Intervention, Educational 12 Radiotherapy 11 Counseling 11 naloxegol 10 Standard of Care 10 Educational Status 10 Tirzepatide 8 Psychiatric Rehabilitation 8 Nutrition Assessment 8 Diet Therapy 8 Diet 8 Therapeutics 7 Resistance Training 7 Interviews as Topic 7 Cisplatin 7 alvimopan 6 Caloric Restriction 6 semaglutide 5 Radiation 5 Liraglutide 5 Exenatide 5 Diet, Mediterranean 5 Dexamethasone 5 Blood Specimen Collection 5 Bariatric Surgery 5 Specimen Handling 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed

61 enrolled 12 charts

Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡